Bedrocan welcomes new European monograph for cannabis flowers

Europe has now the long-awaited quality standard monograph for cannabis flowers. The European Pharmacopoeia Commission officially published the monograph at the beginning of the year, and it will come into force as of July 2024. Many experts and members of the cannabis industry were invited to collaborate on the content. Now that the document has been officially published, Bedrocan welcomes the launch of official quality requirements for medicinal cannabis and hopes it will push more standardised cannabis legislations in Europe and countries that follow European standards.

More harmonisation

The monograph is an important milestone towards the harmonisation of quality requirements for medicinal cannabis. Currently, cannabis legislations vary a lot between countries. Many countries in and outside the European Union (EU) use the European guidelines as a standpoint for their local legislation regarding the quality of medicines. The standards of the European Pharmacopoeia are legally binding in thirty-nine states, not only in the EU. Many other countries, including the US and Canada, also use it as a reference. The harmonisation of standards on such a scale is beneficial to any conventional pharmaceutical product, but it was urgent for medicinal cannabis. Now, Bedrocan hopes there will be more convergence in quality requirements for medicinal cannabis products worldwide. Tjalling: “I hope and expect the global industry and legislators in various countries to embrace this important step forward now set by the EDQM.”